BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

22 related articles for article (PubMed ID: 9475305)

  • 1. Vacuum-Assisted Needle-Free Capillary Blood Sampling.
    Hoffman M; McKeage J; Ruddy B; Nielsen P; Taberner A
    J Diabetes Sci Technol; 2023 Mar; ():19322968231161361. PubMed ID: 36932660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric Dosing and Body Size in Biotherapeutics.
    Shi R; Derendorf H
    Pharmaceutics; 2010 Dec; 2(4):389-418. PubMed ID: 27721364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Evaluation of the Needle-free Injection System VISION(®) for Growth Hormone Therapy in Children.
    Igarashi Y
    Clin Pediatr Endocrinol; 2006; 15(3):117-22. PubMed ID: 24790331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of recombinant human growth hormone administered by cool.click 2, a new needle-free device, compared with subcutaneous administration using a conventional syringe and needle.
    Brearley C; Priestley A; Leighton-Scott J; Christen M
    BMC Clin Pharmacol; 2007 Oct; 7():10. PubMed ID: 17922895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal cognitive function in treated congenital hypopituitarism.
    Brown K; Rodgers J; Johnstone H; Adams W; Clarke M; Gibson M; Cheetham T
    Arch Dis Child; 2004 Sep; 89(9):827-30. PubMed ID: 15321857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormalities of GH secretion in a young girl with Floating-Harbor syndrome.
    Cannavò S; Bartolone L; Lapa D; Venturino M; Almoto B; Violi A; Trimarchi F
    J Endocrinol Invest; 2002 Jan; 25(1):58-64. PubMed ID: 11883867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical testing results and high patient satisfaction with a new needle-free device for growth hormone in young children.
    Silverstein JH; Murray FT; Malasanos T; Myers S; Johnson SB; Frye K; Grossman M
    Endocrine; 2001 Jun; 15(1):15-7. PubMed ID: 11572320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The level of bioavailable growth hormone (GH) after the first GH injection predicts the first year's growth response in GH-deficient children.
    Bozzola M; Radetti G; Pagani S; Draghi M; Aimaretti G; Rondini G
    J Endocrinol Invest; 1999 Nov; 22(10):790-5. PubMed ID: 10614529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioavailability and bioactivity of three different doses of nasal growth hormone (GH) administered to GH-deficient patients: comparison with intravenous and subcutaneous administration.
    Laursen T; Grandjean B; Jørgensen JO; Christiansen JS
    Eur J Endocrinol; 1996 Sep; 135(3):309-15. PubMed ID: 8890721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and pharmacodynamics of recombinant human growth hormone by subcutaneous jet- or needle-injection in patients with growth hormone deficiency.
    Houdijk EC; Herdes E; Delemarre-Van de Waal HA
    Acta Paediatr; 1997 Dec; 86(12):1301-7. PubMed ID: 9475305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of a single dose of recombinant human growth hormone after subcutaneous administration by jet-injection: comparison with conventional needle-injection.
    Verhagen A; Ebels JT; Dogterom AA; Jonkman JH
    Eur J Clin Pharmacol; 1995; 49(1-2):69-72. PubMed ID: 8751024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone (GH) replacement in GH-deficient adults: a crossover trial comparing the effect on metabolic control, well-being and compliance of three injections per week versus daily injections.
    Johansson JO; Wirén L; Oscarsson J; Bengtsson BA; Johannsson G
    Growth Horm IGF Res; 2003 Dec; 13(6):306-15. PubMed ID: 14624763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
    Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
    Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioavailability and bioactivity of intravenous vs subcutaneous infusion of growth hormone in GH-deficient patients.
    Laursen T; Møller J; Jørgensen JO; Orskov H; Christiansen JS
    Clin Endocrinol (Oxf); 1996 Sep; 45(3):333-9. PubMed ID: 8949572
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.